TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
GILD

Gilead Sciences Inc

Healthcare · Drug Manufacturers - General

150.90$ +2.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

Gilead Sciences Inc (GILD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 10,019 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GILD
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12,818 21,250 17,047 11,898 8,400 9,144 8,168 11,384 9,072 8,006 10,828 10,019
1,050 1,098 1,158 1,286 1,429 1,404 1,480 2,050 2,103 2,693 2,767 2,760
360 382 380 638 845 636 643 635 637 766 835 894
-257 -620 475 860 2,010 -478 6,535 11,384 3,509
-518 1,495 1,546 5,108 -939 -798 -1,638 489 -1,763 -2,303 -880 -3,948
557 747 748 590 924 825 650 579 728 585 523 563
-1,823 -12,475 -11,985 -16,069 14,355 -7,817 -14,615 -3,131 -2,466 -2,265 -3,449 -4,793
6,382 1,874 2,455 2,731 2,971 3,222 3,449 3,605 3,709 3,809 3,918 4,003
-5,349 -10,002 -11,001 -954 -2,900 -1,749 -1,583 -546 -1,396 -1,000 -1,150 -1,922
5,696 9,689 4,268 7,174 -6,250 -2,750 5,684 -4,750 -1,500 -270 1,494 -1,788
-3,025 -5,884 -9,725 3,393 -12,318 -7,634 770 -8,877 -6,469 -5,125 -3,433 -7,745
7,914 2,824 -4,622 -641 10,352 -6,309 -5,634 -659 74 673 3,906 -2,427
12,261 20,503 16,299 11,308 7,476 8,319 7,518 10,805 8,344 7,421 10,305 9,456

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?